RIVERSIDE MED CTR — History
CCN 191313 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
+16.1%
Revenue CAGR (3yr)
-33.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $23M | $25M | +9.2% | +16.1% |
| Operating Expenses | $30M | $33M | $34M | +3.2% | +6.3% |
| Operating Margin | -59.2% | -41.3% | -33.6% | +18.7% | +0.0% |
| Net Income | $-11M | $-10M | $-9M | +11.2% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,170 | 1,418 | 1,124 | -20.7% | -2.0% |
| Medicare Day % | 56% | 40% | 48% | +18.8% | -8.0% |
| Medicaid Day % | 1% | 1% | 1% | +40.2% | +2.0% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +34.7% ($19M → $25M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+16.1%
This Hospital
+7.6%
State Avg
Latest Margin
-33.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | -20.8% |
| FY2024 (proj) | $32M | -8.0% |
| FY2025 (proj) | $35M | 4.7% |